GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 36 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,268,057 | $8,641,297 | 1.69% |
| Vivo Capital, LLC | 3,969,427 | $15,123,517 | 1.04% |
| Logos Global Management LP | 1,800,000 | $6,858,000 | 0.93% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,665 | $4,681,214 | 0.73% |
| Orbimed Advisors | 9,033,726 | $34,418,496 | 0.62% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $37,726,391 | 0.22% |
| Baker Brothers Advisors | 1,000,000 | $3,810,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 543,687 | $2,071,446 | 0.02% |
| Point72 Asset Management, L.P. | 1,000,000 | $3,810,000 | 0.01% |
| Bellevue Group AG | 145,646 | $554,911 | 0.01% |